53733-97-4

Basic information

• Product Name: Z-BETA-ALA-OSU
• Synonyms: Z-BETA-ALANINE HYDROXYSUCCINIMIDE ESTER;Z-BETA-ALANINE N-HYDROXYSUCCINIMIDE ESTER;Z-BETA-ALANINE-OSU;Z-BETA-ALA-OSU;Z-β-Alanine N-hydroxysuccinimide ester;Z-B-ALANINE HYDROXYSUCCINIMIDESTER;CBZ-.BETA.-ALANINE N-HYDROXYSUCCINIMIDE ESTER;Z-b-Ala-OSu
• CAS NO: 53733-97-4
• Molecular Formula: C₁₅H₁₆N₂O₆
• Molecular Weight: 320.3
• Mol File: 53733-97-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: Z-BETA-ALA-OSU(CAS DataBase Reference)
• NIST Chemistry Reference: Z-BETA-ALA-OSU(53733-97-4)
• EPA Substance Registry System: Z-BETA-ALA-OSU(53733-97-4)

Safety Data

• Hazardous Substances Data: 53733-97-4(Hazardous Substances Data)

Usage

Description

Z-BETA-ALA-OSU is a synthetic chemical compound derived from beta-alanine, an amino acid involved in the synthesis of carnosine, which possesses antioxidant and protective properties. As a potential prodrug, Z-BETA-ALA-OSU can be converted into a pharmacologically active form within the body. It has been studied for its possible anti-inflammatory and neuroprotective properties, making it a promising candidate for therapeutic applications in treating neurodegenerative diseases and chronic inflammatory disorders.

Uses

Used in Pharmaceutical Applications:
Z-BETA-ALA-OSU is used as a prodrug for its potential conversion into a pharmacologically active form within the body, offering therapeutic benefits.
Used in Neurodegenerative Disease Treatment:
Z-BETA-ALA-OSU is used as a neuroprotective agent for its potential to protect neurons and mitigate the progression of neurodegenerative diseases.
Used in Chronic Inflammatory Disorder Treatment:
Z-BETA-ALA-OSU is used as an anti-inflammatory agent to reduce inflammation and alleviate symptoms associated with chronic inflammatory disorders.
Further research is required to fully understand the potential uses and effects of Z-BETA-ALA-OSU in various medical applications.

Upstream product

• 501-53-1 benzyl chloroformate 
• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 2304-94-1 3-(benzyloxycarbonylamino)propanoic acid 

Downstream Products

• 60722-81-8 [(R)-2-(3-Benzyloxycarbonylamino-propionylamino)-3-(4-bromo-benzylsulfanyl)-propionylamino]-acetic acid 
• 21612-32-8 (±)-Cbz-βAla-Phe-OH 
• 1133822-85-1 spiro[(4-ethyl-7,8-dihydropyrano[3,2-g]chromen-2-one)-8,1'-cyclohexane] N-(N-benzyloxycarbonyl-β-alanyl)hydrazone 
• 1098518-73-0 C₂₂H₃₀N₂O₇ 
• 108257-19-8 (2-{[(2R,3S,4R,5R)-5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamoyl}-ethyl)-carbamic acid benzyl ester 

Relevant articles and documents

Synthesis of amino acid derivatives of hydrazones and oximes of spirodihydropyranochromen-2-ones

Sulfur-and nitrogen-containing derivatives of spirodihydropyranochromen-2- ones at the exocyclic oxygen atom have been synthesized. Modification of the oximes and hydrazones of the spiro-substituted pyranocoumarins with N-substituted amino acids were carried out using activated ester and symmetrical anhydride methods.

Compositions for the delivery of negatively charged molecules

This invention features permeability enhancer molecules, and methods, to increase membrane permeability of negatively charged polymers thereby facilitating cellular uptake of such polymers.

Bridged isocytosine-adenosine compounds: Synthesis and antibacterial evaluation

-